T1	Participants 56 111	patients after hematopoietic stem cell transplantation.
T2	Participants 314 471	One hundred fifty-seven patients were screened for cognitive deficits following HSCT for malignant diseases at an in-patient oncologic rehabilitation clinic.
T3	Participants 472 639	Patients showing evidence of impairment were randomly assigned to one of two training groups: individualized PC-supported training or neuropsychological group therapy.
T4	Participants 640 714	The control group consisted of patients who received no specific training.
